Heat threatens medication safety during extreme summer weather
Medications increase heat-illness risk; French study investigating medication-heat hospitalization links after 24,000+ summer emergency visits.
Event / Health
Student Prescription Drug Misuse
Growing phenomenon of prescription medication misuse among students for cognitive enhancement, including market expansion, health risks, medication safety during extreme heat, and regulatory concerns.
3 reported locations
Daily activity
0 articles0 articles
2026-08-16 to 2026-11-13 · UTC publication dates
Coverage begins 18 Jun, 09:34 UTC
Follow the documented timeline or explore the related reporting.
What happened
French regional pharmacovigilance center plans study linking medications to heat-related hospitalizations
Starting in 2026, the Regional Pharmacovigilance Centre of Toulouse plans to analyze hospitalizations and deaths potentially linked to adverse medication effects exacerbated by extreme heat, using health insurance data and weather information to quantify risk levels.
Cambridge University study shows cognitive enhancers reduce solution quality for complex problems
Research from Cambridge University found that prescription stimulants used for cognitive enhancement increase motivation but also reduce the quality of effort needed to solve complex problems, negating the motivational benefit.
Ritalin and Modafinil are prescription medications being diverted for cognitive enhancement
Ritalin, prescribed for attention deficit disorders, and Modafinil, used to treat narcolepsy, are prescription medications being diverted from their intended medical purposes. Students and young people obtain these drugs through social networks, diverted markets, and individuals with legitimate prescriptions who share their medications.
Energy drink consumption reported by 11% of French students
According to a survey by Les Sherpas, 11% of French students report using energy drinks, which health professionals advise against due to potential adverse effects.
Prescription stimulants carry documented health risks including sleep disruption and cardiac effects
The French National Agency for the Safety of Medicines and Health Products documented that psychostimulant medications can cause adverse effects including sleep disorders, headaches, nervousness, irritability, heart palpitations, loss of appetite, and abdominal pain.
French summer 2025 recorded over 24,000 emergency visits for heat-related illnesses
During summer 2025, France recorded more than 24,000 emergency medical visits for conditions related to extreme heat, including hyperthermia, dehydration, and hyponatremia.
Heat can compromise effectiveness of medical devices and medication patches
High temperatures can alter the effectiveness of medical devices such as blood glucose monitoring strips used by diabetics. Excessive perspiration can also change the effectiveness of medications delivered through transdermal patches.
4% of French youth aged 14-20 report consuming prescription medications before exams
A survey conducted by Les Sherpas, a French educational support company, found that 4% of young people between 14 and 20 years old in France reported consuming prescription medications before their exams.
Certain medications increase risk of heat-related complications during periods of extreme heat
Multiple classes of medications including neuroleptics, antimigraine drugs, and powerful pain medications (opioids) can lower blood pressure or cause drowsiness, increasing the risk of dehydration and heat-related complications. Photosensitizing medications can cause skin reactions upon sun exposure.
Global market for cognitive-enhancing drugs reached nearly 4 billion dollars in 2024
The global market for prescription drugs used off-label as cognitive enhancers, known as 'smart drugs,' reached approximately 4 billion dollars in 2024, according to research by Credence Research. This represents significant growth from 1.7 billion dollars in 2018.
Read the coverage
2 alternative perspectives
Cognitive enhancers boost market but raise efficacy and health concerns
Cognitive enhancers fuel a $4B market but research questions efficacy and raises safety concerns.